Search results
Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
Investor's Business Daily· 1 day agoMounjaro and Trulicity were partly to blame for the light sales quarter. Mounjaro brought in $1.81...
Columbia is facing a bigger donor revolt than we thought
INSIDER via Yahoo News· 5 hours agoUnlike outspoken billionaires, the Berrie Foundation exerted influence behind the scenes. Columbia...
How a common diabetes drug may help prolong our health- and lifespan
Medical News Today· 4 days agoMetformin is an oral prescription drug widely used to control blood sugar in type 2 diabetes....
New Weight-Loss, Diabetes Drugs Reach One in Eight Americans
Bloomberg· 14 hours agoOne in eight US adults has tried medications from the fast-growing class of new diabetes and obesity...
Prevention of Diabetes Complications Lags in Latin America
Medscape· 18 hours agoAn alarming lack of compliance with assessments to prevent ophthalmologic and neuropathic complications associated with diabetes has been detected in nine countries in Latin ...
Young People with Diabetes May Face Higher Alzheimer's Risk
Healthline via AOL· 15 hours agoA new study suggests that early-onset diabetes may increase the risk of Alzheimer’s disease....
Illinois bill would expand insurance coverage for diabetes treatments
FOX News Chicago· 1 day agoA proposed bill in the Illinois state legislature aims to broaden insurance coverage for all forms...
Signs of juvenile diabetes in your child
Rolling Out· 3 days agoDiabetes is increasingly becoming a major health concern among children worldwide. Early detection and management are crucial in mitigating the risks...
The New Seasonal Eating Breakthrough That Helps You Ditch The Weight-Gain Blame Game, Reverse ...
First for Women via Yahoo News· 13 hours ago“After having seen so many reversals of diabetes, we think it should be viewed as a repetitive...
One in eight U.S. adults have taken Ozempic or similar weight loss drugs
Dallas Morning News· 8 hours agoOne in eight US adults has tried medications from the fast-growing class of new diabetes and obesity...